peptide version of tirzepatide Research: Comprehensive Review Studies and Mechanisms TIRZEPATIDE 15 mg – Peptide
Description
Your specific target depends on your starting weight, activity level, and current tirzepatide dose
It is your responsibility to review this disclaimer regularly for any changes
Based on clinical trial data: Month 1 (2.5 mg): ~2 lb
Explore a Different Path: This is the option that is empowering thousands of patients who are tired of fighting a losing battle with their insurance
They were among the first platforms to offer sublingual (under the tongue) versions of both semaglutide and tirzepatide, which may appeal to patients who prefer not to inject
In these trials, MOUNJARO (5 mg, 10 mg, and 15 mg given subcutaneously once weekly) was compared with placebo, semaglutide 1 mg, insulin degludec, and/or insulin glargine [see Clinical Studies (14.2, 14.3, 14.4)]
